Home Tags Asthma

Asthma Related Content

Pneumology & Pulmonary Cell Research university hospital basel

Where are the new asthma drugs?

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...
finnish allergy

The Finnish Allergy Programme 2008-2018: Reducing the burden of allergy in both patients and...

Managing director of the Finnish Allergy, Skin and Asthma Federation, Ilkka Repo explores The Finnish Allergy Programme 2008-2018 and what it sets out to do The Finnish Allergy Programme 2008-2018 was initiated to reduce the burden of allergy in both patients and society. The set-up of the programme was unique....
Innovative Therapies

Developing innovative therapies to treat asthma

Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...
allergic rhinitis

Allergic rhinitis is scary, but health is around the corner

Roberta Savli from EFA provides insight into allergic rhinitis Rhinitis is a very common disorder, far more than just sneezing a couple of days in the year. Allergic rhinitis is a serious chronic respiratory disease that reduces patients’ quality of life and their productivity at work and at school. Despite...
Pneumology & Pulmonary Cell Research

Pneumology & Pulmonary Cell Research

Prof Dr Michael Roth (PhD) at University Hospital Basel looks at pneumology & pulmonary cell research, in this profile of the organisation's research
asthma

Europe can lead the way to a cure for asthma

Susanna Palkonen of the European Federation of Allergies and Airways Diseases Patients’ Associations underlines research around asthma in Europe today
ARDs

New biomarkers of lung injury in ARDS

Associate professor at CHU Clermont-Ferrand, Université Clermont Auvergne, Matthieu Jabaudon highlights the hopeful future for ARDS

Asthma: How to treat and prevent the high impact disease

Sereina de Zordo from the aha! Swiss Allergy Centre outlines the global burden of asthma and how through various methods and programmes it can be managed

Follow Open Access Government